Bio-Rad launches validated antibodies for rare cell and circulating tumor cell enumeration

Antibodies validated for use with Bio-Rad’s Celselect Slides™ enumeration stain kits to enable immunostaining of captured circulating tumor cells in liquid biopsy samples.

Patient Who Had No Luck With GLP-1 Drugs Found Success With Surgery

This story is part of a series called “Ozempic: Weighing the Risks and Benefits.” It was produced in part through a grant from the NIHCM

December 24, 2024

Health tech startups Commure and Athelas are merging with a $70M boost from General Catalyst

A pair of health tech startups backed by the same VC are merging to complement the services they offer and bring those services to more

October 6, 2023

Overcoming regulatory issues with investigational medicinal product labelling

Accuracy is vital for the text on labels of medical products, especially with language barriers between manufacturers and patients. Credit: via Shutterstock. Meeting strict client

June 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.